Annual Working Capital
$12.03 M
-$3.37 M-21.87%
December 31, 2022
Summary
- As of February 10, 2025, BVXV annual working capital is $12.03 million, with the most recent change of -$3.37 million (-21.87%) on December 31, 2022.
- During the last 3 years, BVXV annual working capital has fallen by -$3.61 million (-23.08%).
Performance
BVXV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$5.88 M
-$2.58 M-30.52%
June 30, 2023
Summary
- As of February 10, 2025, BVXV quarterly working capital is $5.88 million, with the most recent change of -$2.58 million (-30.52%) on June 30, 2023.
- Over the past year, BVXV quarterly working capital has increased by +$1.10 million (+22.98%).
Performance
BVXV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BVXV Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.9% | +23.0% |
| 3 y3 years | -23.1% | -41.8% |
| 5 y5 years | -38.9% | -45.0% |
BVXV Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.9% | at low | -61.8% | -18.7% |
| 5 y | 5-year | -23.1% | -238.4% | -62.4% | -383.2% |
| alltime | all time | -38.9% | -238.4% | -73.6% | -383.2% |
BiondVax Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $5.88 M(-30.5%) |
| Mar 2023 | - | $8.47 M(-29.6%) |
| Dec 2022 | $12.03 M(-21.9%) | $12.03 M(+72.1%) |
| Sep 2022 | - | $6.99 M(+46.1%) |
| Jun 2022 | - | $4.78 M(-62.9%) |
| Mar 2022 | - | $12.89 M(-16.3%) |
| Dec 2021 | $15.40 M(-192.4%) | $15.40 M(-245.1%) |
| Sep 2021 | - | -$10.61 M(+28.6%) |
| Jun 2021 | - | -$8.25 M(+56.1%) |
| Mar 2021 | - | -$5.29 M(-68.3%) |
| Dec 2020 | -$16.66 M(-206.5%) | -$16.66 M(-447.1%) |
| Sep 2020 | - | $4.80 M(-52.5%) |
| Jun 2020 | - | $10.11 M(-35.3%) |
| Dec 2019 | $15.64 M(+7.0%) | $15.64 M(-26.4%) |
| Sep 2019 | - | $21.26 M(+202.0%) |
| Jun 2019 | - | $7.04 M(-39.4%) |
| Mar 2019 | - | $11.63 M(-20.4%) |
| Dec 2018 | $14.62 M | $14.62 M(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $14.67 M(+37.3%) |
| Jun 2018 | - | $10.69 M(-24.0%) |
| Mar 2018 | - | $14.06 M(-28.6%) |
| Dec 2017 | $19.69 M(+205.8%) | $19.69 M(-11.7%) |
| Sep 2017 | - | $22.31 M(+107.1%) |
| Jun 2017 | - | $10.77 M(+1.2%) |
| Mar 2017 | - | $10.64 M(+65.2%) |
| Dec 2016 | $6.44 M(-28.7%) | $6.44 M(-11.8%) |
| Sep 2016 | - | $7.30 M(-8.1%) |
| Jun 2016 | - | $7.95 M(-7.7%) |
| Mar 2016 | - | $8.61 M(-4.6%) |
| Dec 2015 | $9.02 M(+222.5%) | $9.02 M(-9.4%) |
| Sep 2015 | - | $9.96 M(-4.1%) |
| Jun 2015 | - | $10.39 M(+368.0%) |
| Mar 2015 | - | $2.22 M(-20.7%) |
| Dec 2014 | $2.80 M(-47.6%) | $2.80 M(-22.1%) |
| Sep 2014 | - | $3.59 M(-32.7%) |
| Dec 2013 | $5.34 M(+25.9%) | $5.34 M |
| Dec 2012 | $4.24 M | - |
FAQ
- What is BiondVax Pharmaceuticals annual working capital?
- What is the all time high annual working capital for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual working capital year-on-year change?
- What is BiondVax Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly working capital year-on-year change?
What is BiondVax Pharmaceuticals annual working capital?
The current annual working capital of BVXV is $12.03 M
What is the all time high annual working capital for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual working capital is $19.69 M
What is BiondVax Pharmaceuticals annual working capital year-on-year change?
Over the past year, BVXV annual working capital has changed by -$3.37 M (-21.87%)
What is BiondVax Pharmaceuticals quarterly working capital?
The current quarterly working capital of BVXV is $5.88 M
What is the all time high quarterly working capital for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly working capital is $22.31 M
What is BiondVax Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, BVXV quarterly working capital has changed by +$1.10 M (+22.98%)